Modern possibilities of topical therapy of upper respiratory tract and throat infectious inflammatory diseases

Introduction. At the present moment, the healthcare system has faced significant problems in terms of infectious safety: an unprecedented increase in the spectrum of pathogenic microorganisms, the annual appearance of 1-2 “new” infectious diseases, an increase in the proportion of emergent infections, especially of viral etiology, against which there are no effective drugs, and the spread drug-resistant microorganisms, as well as the establishment of a direct etiological or trigger role of microbial agents in the development of somatic human pathology.

The aim of our work was to evaluate the topical preparation (amylmetacresol and dichlorobenzyl alcohol) used to stop the inflammatory process and eliminate pain in patients with pharyngeal diseases.

Patients and methods. We studied the antimicrobial, antiviral and anti-inflammatory effect of a fixed combination of 2,4-dichlorobenzyl alcohol 1.2 mg, amylmethacresol 0.6 mg. 20 patients with manifestations of inflammatory changes in the pharyngeal cavity underwent treatment with Strepsils resorption tablets according to the scheme. The control group consisted of 10 patients who received therapy according to the usual scheme.

Results and discussion. As a result of the therapy, sore throat in patients in the first group completely disappeared amongst 15 patients, and its intensity significantly decreased amongst 5 patients. Patients noted that the use of Strepsils resorption tablets reduces the sensation of a foreign body, irritation in the pharynx and oral cavity; eliminates pain, tickle, feeling of soreness in the throat. The analgesic effect of the drug manifested itself after about 5 minutes and lasted up to 2 hours. By the end of the treatment, all patients from this group had unpleasant sensations and discomfort completely stopped.

Conclusion. Amylmethacresol/Dichlorobenzyl Absorption Tablets is a well-tolerated and effective over-the-counter treatment offering functional, sensory and emotional benefits for patients with acute sore throat, providing a quick onset of effect and may be more relevant and suitable than antibiotics when pharyngitis associated with viral infections of the upper respiratory tract.

1. Nochi T., Kiyono H. Innate immunity in the mucosal immune system. Current Pharmaceutical Design. 2006;12(32):4203–4213. doi: 10.2174/138161206778743457.

2. Shestakova I.V. The infectious diseases morbidity in the Russian Federation, 2000-2015: success or failure? Infekcionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training. 2017;(3):11–20. (In Russ.) Available at: https://cyberleninka.ru/article/n/infektsionnaya-zabolevaemost-v-rossiyskoy-federatsii-v-2000-2015-gguspeh-ili-proval.

3. Bakulina L.S., Zhdanova I.Yu. Condition of the pharyngeal mucosa of patients with chronic pharyngitis. In: YAnov YU.K., Ryazantsev S.V., Tulkin V.N. (ed.). Materials of the VIII St.­Petersburg International Forum of Otorhinolaryngologists of Russia. St.-Petersburg.: Poliforum; 2019, pp. 193– 194. (In Russ.) Available at: http://viii-forum-spb2019.ent-congress.ru/materials.html.

4. Wade A.G., Morris C., Shephard A., Crawford G.M., Goulder MA. A multicentre randomized double-blind single-dose study assessing the efficacy of AMC/DCBA warm lozenge or AMC/DCBA cool lozenge in the relief of acute sore throat. BMC Family Practice. 2011;12(6):1–14. doi: 10.1186/1471-2296-12-6.

5. Roxas M., Jurenka J. Colds and influenza: a review of diagnosis and conventional botanical and nutritional considerations. Alternative Medicine Review. 2007;12(1):25–48. Available at: http://archive.foundationalmedicinereview.com/publications/12/1/25.pdf.

6. Matalygina O.A. Formation of individual preventive measures for identification of minimum disease risks in children aged 3 to 18 years. Methodological recommendations for physicians. St. Petersburg: Simvol; 2012. 352 p. (In Russ.)

7. Becker W.N. (eds.), Naumann H.H., Pfaltz C.R. Ear, nose and throat diseases: a pocket reference (authorised translation). 2rd ed. Thieme Publications; 1994. 583 p.

8. Hurst D.S. The Role of Allergy in Otitis Media with Effusion. Otolaryngologic Clinics of North America. 2011;44(3):637–654. doi: 10.1016/j.otc.2011.03.009.

9. Oxford J.S., Lambkin R., Gibb I., Balasingam S., Chan C., Catchpole A. A throat lozenge containing amylmetacresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus influenza A and SARs-CoV. Antivir Chem Chemother. 2005;16(2):129–134. doi: 10.1177/095632020501600205.

10. Renner B., Mueller C.A., Shephard A. Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat). Inflammation Research. 2012; 61(10):1041–1052. doi: 10.1007/s00011-012-0540-9.

11. Marshall S. Giving advice on sore throats. The Pharmaceutical Journal. 2008;280:127–130. Available at: http://www.pharmaceutical-journal.com/libres/pdf/cpd/pj_20080202_sorethroats.pdf.

12. Tatochenko V.K. Respiratory diseases in children. Practical Guide. 7th Edition. Moscow: Borges; 2019. 300 p. (In Russ.)

13. Sharland M., Kendall H., Yeates D., Randall A., Hughes G., Glasziou P. Antibiotic prescribing in general practices and hospital admissions for peritonsillar abscess mastoiditis and rheumatic fever in children: time trend analysis. BMJ. 2005;331(7512):328–329. doi: 10.1136/bmj.38503.706887.AE1.

14. Centre for Clinical Practice at NICE (UK). Respiratory Tract Infections – Antibiotic Prescribing: Prescribing of Antibiotics for Self­Limiting Respiratory Tract Infections in Adults and Children in Primary Care. London: National Institute for Health and Clinical Excellence (UK); 2008. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21698847.

15. Summers A. Sore throats. Accid Emerg Nurs. 2005;13(1):15–17. doi: 10.1016/j.aaen.2004.10.008.

16. Del Mar C.B., Glasziou P.P., Spinks A.B. Antibiotics for sore throat. Cochrane Database Syst Rev. 2006;(4):CD000023. doi: 10.1002/14651858.CD000023.pub3.

17. Shevchik E.A., Nikiforova G.N., Bidanova D.B. Topical therapy of inflammatory pharyngeal diseases. Meditsinskiy sovet = Medical Council. 2016;(18):121– 123. (In Russ.) doi: 10.21518/2079-701X-2016-18-121-123.

18. Kelly F. Something for a sore throat please the possible causes and treatments for a sore throat. Australian Pharmacist. 2008;27(5):394–397.

19. Limb M., Connor A., Pickford M., Church A., Mamman R., Reader S. Scintigraphy can be used to compare efficacy of sore throat formulations.

20. Int J Clin Pract. 2009;63(4):606–612. doi: 10.1111/j.1742-1241.2008.01984.x. 20. Aleksandrov A.N., Boboshko M.Yu., Glukhova Ye.Yu., Karpishchenko S.A., Katinas Ye.B., Lavrenova G.V. Drug reference book for ENT doctors and general practitioners. Sankt-Peterburg: Dialog; 2010. 620 p. (In Russ.)

21. Coulthard C.E. The Disinfectant and Antiseptic Properties of Amyl-metacresol. Br J Exp Pathol. 1931;12(5):331–336. Available at: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC2048245/.

22. Schachtel B., Aspley S., Shephard A., Shea T., Smith G., Sanner K. Onset of action of a lozenge containing flurbiprofen 8.75 mg: a randomized, double-blind, placebo-controlled trial with a new method for measuring onset of analgesic activity. Pain. 2014;155(2):422–428. doi: 10.1016/j.pain.2013.11.001.

23. de Looze F., Russo M., Bloch M., Montgomery B., Shephard A., Smith G. Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial. Eur J Gen Pract. 2016;22(2):111–118. doi: 10.3109/13814788.2016.1145650.

24. Imberti R., De Gregori S., Lisi L., Navarra P. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm. Pharmacology. 2014;94(3–4):143–147. doi: 10.1159/000367663.

25. Aspley S., Shephard A., Schachtel E., Sanner K., Savino L., Schachtel B. Efficacy of flurbiprofen 8.75 mg lozenge in patients with a swollen and inflamed sore throat. Curr Med Res Opin. 2016;32(9):1529–1538. doi: 10.1080/03007995.2016.1187119.

26. Eccles R. Mechanisms of symptoms of the common cold and influenza. Br J Hosp Med (Lond). 2007;68(2):71–75. doi: 10.12968/hmed.2007.68.2.22824.